Protalix BioTherapeutics (PLX) EBITDA Margin (QoQ) (2010 - 2026)
Protalix BioTherapeutics (PLX) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Protalix BioTherapeutics | 190.95 Mn | 180.16 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,372.00 |
| Dec 31, 2025 | -6,300.00 |
| Sep 30, 2025 | 445.00 |
| Jun 30, 2025 | 4,847.00 |
| Mar 31, 2025 | -8,056.00 |
| Dec 31, 2024 | 1,735.00 |
| Sep 30, 2024 | 4,024.00 |
| Jun 30, 2024 | 11,155.00 |
| Mar 31, 2024 | -7,601.00 |
| Dec 31, 2023 | -3,531.00 |
| Sep 30, 2023 | -7,646.00 |
| Jun 30, 2023 | 8,387.00 |
| Mar 31, 2023 | 331.00 |
| Dec 31, 2022 | -692.00 |
| Sep 30, 2022 | 4,108.00 |
| Jun 30, 2022 | -5,148.00 |
| Mar 31, 2022 | 5,512.00 |
| Dec 31, 2021 | -5,111.00 |
| Sep 30, 2021 | 12,698.00 |
| Jun 30, 2021 | -10,989.00 |